44 results
6-K
EX-99
BLRX
Bioline Rx Ltd
24 Feb 14
BioLineRx Appoints Dr. Sandra Panem to
12:00am
and life sciences industries in the U.S. Her experience encompasses corporate and financial strategy, corporate governance, venture capital
6-K
EX-99
BLRX
Bioline Rx Ltd
24 Dec 14
Current report (foreign)
12:00am
limitations in place on Novartis’ ability to sell shares in the future
Corporate governance is very strong
– No board seat for Novartis
6-K
EX-1
BLRX
Bioline Rx Ltd
28 May 19
Current report (foreign)
7:04am
of Compensation6
A-3
Motivation and Retention
A-3
Corporate Governance
A-6
Compensation Committee Membership and Duties
A-6
Policy Confirmation, Amendment … package of fixed and variable elements, each designed to impact in a specific manner the motivation and retention of employees.
Corporate Governance
Compensation
6-K
EX-99
BLRX
Bioline Rx Ltd
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
Components of Compensation
A-7
2.6.
Motivation and Retention
A-7
Corporate Governance
A-8
3.1.
Compensation Committee Membership and Duties
A-8
3.2 … in a specific manner the motivation and retention of employees.
A - 7
BioLineRx Compensation Policy for Executive and Directors
Corporate Governance
3.1
6-K
EX-99.3
xemg6wsn
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-2
1vcz r3p1
23 Aug 11
Condensed Consolidated Interim Financial Statements
12:00am
20-F
ayj87z
22 Mar 12
Annual report (foreign)
12:00am
20-F/A
b2nne
26 Mar 24
Annual report (foreign) (amended)
4:57pm
F-1
x3mzrk5u6z5
24 Sep 10
Registration statement (foreign)
12:00am